Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Cancer Face”

135 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 135 results

Not applicableStudy completedNCT00609505
What this trial is testing

Telemedicine vs. Face-to-Face Cancer Genetic Counseling

Who this might be right for
Hereditary Breast and Ovarian Cancer SyndromeLynch Syndrome
Duke University 130
Testing effectiveness (Phase 2)Study completedNCT01475955
What this trial is testing

Short-incubation Levulan Photodynamic Therapy Versus Vehicle for Face/Scalp Actinic Keratosis (AK)

Who this might be right for
Actinic Keratosis
DUSA Pharmaceuticals, Inc. 235
Not applicableStudy completedNCT04286698
What this trial is testing

Two Different Physiotherapy Programs in Lymphedema Following Head and Neck Cancer Treatment

Who this might be right for
Head and Neck CancerLymphedema of FaceFibrosis; Skin
Izmir Bakircay University 21
Testing effectiveness (Phase 2)Study completedNCT02838628
What this trial is testing

Activity & Safety Study of KX2-391 Ointment in Participants With Actinic Keratosis on the Face or Scalp

Who this might be right for
Actinic Keratosis
Almirall, S.A. 168
Large-scale testing (Phase 3)Study completedNCT01541553
What this trial is testing

A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp

Who this might be right for
Actinic Keratosis
LEO Pharma 367
Early research (Phase 1)Study completedNCT05060237
What this trial is testing

Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp

Who this might be right for
Actinic KeratosisKeratosis, ActinicKeratosis
Biofrontera Bioscience GmbH 112
Testing effectiveness (Phase 2)Study completedNCT06159842
What this trial is testing

Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (isSCC)

Who this might be right for
Facial Cutaneous Squamous Cell Carcinoma in Situ
The Center for Clinical and Cosmetic Research 32
Early research (Phase 1)Study completedNCT02411851
What this trial is testing

Treatment of Actinic Keratoses (AK) on the Face

Who this might be right for
Actinic Keratoses
Icahn School of Medicine at Mount Sinai 20
Large-scale testing (Phase 3)Study completedNCT00936741
What this trial is testing

An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome

Who this might be right for
Cushing's Syndrome
Corcept Therapeutics 30
Large-scale testing (Phase 3)Study completedNCT00569582
What this trial is testing

The Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome

Who this might be right for
Cushing's Syndrome
Corcept Therapeutics 50
Not applicableStudy completedNCT07095348
What this trial is testing

Relationship Between Serum Xanthine Oxidase Levels and Seborrheic Keratosis

Who this might be right for
Seborrheic Keratosis (SK)Oxidative StressSkin Aging
Sri Nauli Dewi Lubis 80
Post-approval studies (Phase 4)Study completedNCT03511326
What this trial is testing

PRO With Luxerm® in the Field Treatment of Thin and Non-hyperkeratotic Non-pigmented AK

Who this might be right for
Actinic Keratoses
Galderma R&D 50
Early research (Phase 1)Study completedNCT02248298
What this trial is testing

Efficacy of AFL-assisted PDT With Short Incubation Time in Actinic Keratosis

Who this might be right for
Actinic Keratosis
Dong-A University 93
Testing effectiveness (Phase 2)Study completedNCT01922050
What this trial is testing

Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis

Who this might be right for
Actinic Keratosis
LEO Pharma 320
Post-approval studies (Phase 4)Study completedNCT00777127
What this trial is testing

Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses

Who this might be right for
Actinic Keratosis
MEDA Pharma GmbH & Co. KG 258
Not applicableStudy completedNCT01502020
What this trial is testing

A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic Keratoses

Who this might be right for
Actinic Keratoses
Actavis Mid-Atlantic LLC 410
Not applicableStudy completedNCT05260073
What this trial is testing

Patient and Clinician Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis

Who this might be right for
Keratosis, Actinic
Almirall, S.A. 300
Early research (Phase 1)Study completedNCT01836367
What this trial is testing

Ingenol Mebutate 0.015% Gel in the Treatment of Actinic Keratoses (AK) on the Face and Scalp

Who this might be right for
Actinic Keratosis
Icahn School of Medicine at Mount Sinai 20
Large-scale testing (Phase 3)Study completedNCT00915551
What this trial is testing

A Multi-Center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp)

Who this might be right for
Actinic Keratosis
Peplin 278
Testing effectiveness (Phase 2)Study completedNCT02654717
What this trial is testing

Eight Week Study of Treatment With DFD-07 for Actinic Keratosis of the Face and Scalp

Who this might be right for
Actinic Keratosis
Promius Pharma, LLC 111
Next Page